Psoriasis and hemorheology. Influence of the metabolic syndrome

Clinical Hemorheology and Microcirculation

Volumn 55, Issue 3, 2013, Pages 331-339

  Vayá, Amparo ^a   Ricart, Jose M ^a   Andino, Belinda ^a   Todoli, Jose ^a   Nuñez, Cornelio ^a   Calvo, Javier ^b   Bautista, Daniel ^c  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Hemorheolgy; Metabolic syndrome; Psosiasis

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD RHEOLOGY; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL (TOPIC); ERYTHROCYTE AGGREGATION; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEUTROPHIL; PLASMA VISCOSITY; PROTEIN BLOOD LEVEL; PSORIASIS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

HEMORHEOLGY; METABOLIC SYNDROME; PSOSIASIS;

BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; FEMALE; HEMORHEOLOGY; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PSORIASIS; RISK FACTORS;

EID: 84891112402     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1639     Document Type: Article

References (31)

1. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleenman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria and S.C. Smith, International Diabetes Federation Task Force on Epidemiology; National Heart. Lung and blood Institute; American Heart association; World Health Federation; International Atherosclerosis society; International Association for the study of obesity. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity, Circulation 120 (2009), 1640-1645.
2. K.G. Alberti and P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet Med 15 (1998), 539-553. (Pubitemid 28319935)
3. K.G. Alberti, P. Zimmet, and J. Shaw, Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation, Diabet Med 23 (2006), 469-480.
4. S. Arias-Santiago, M.A. Arrabal-Polo, S. Garcia-Rodriguez, R. Perandrés-Lopez, J.C. Ruiz, R. Naranjo-Sintes, M. Zubiaur, J. Sancho and A. Buendía-Eisman, Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis. Eur J Dermatol 22 (2012), 337-344.
5. O.K. Baskurt, M. Boynard and C.G. Cokelet, et al., International Expert Panel for Standardization of Hemorheological Methods. New guidelines for hemorheological laboratory techniques, Clin Hemorheol Microcirc 42 (2009), 75-97.
6. J.F. Brun, I. Aloulou and E. Varlet-Marie, Hemorheological aspects of the metabolic syndrome: Markers of insulin resistance, obesity or hyperinsulinemia? Clin Hemorheol Microcirc 30 (2004), 203-209. (Pubitemid 38951505)
7. J.F. Brun, E. Varlet-Marie, E. Raynaud de Mauverger and J. Mercier, Minimal model-derived insulin sensitivity, insulin secretion and glucose tolerance: Relationships with blood rheology, Clin Hemorheol Microcirc 51 (2012), 21-27.
8. C. Carallo, C. Irace, M.S. De Franceschi, F. Coppoletta, R. Tiriolo, C. Scicchitano, F. Scavelli and A. Gnasso, The effect of aging on blood and plasma viscosity. An 11.6 years follow up study, Clin Hemorheol Microcirc 47 (2011), 67-74.
9. A. Chabanel and M. Samama, Evaluation of a method to assess red blood cell aggregation, Biorheology 26 (1989), 785-97. (Pubitemid 19214799)
10. A. Cohen, H. Gilutz, Y. Henkin, D. Zahger, J. Shapiro, D. Bonneh and D. Vardy, Psoriasis and the metabolic syndrome, Acta Derm Venereol 87 (2007), 506-509. (Pubitemid 351373394)
11. B. Davidovici, N. Sattar, J. Prinz, L. Puig, P. Emery, J. Barker, P. van de Kerkhof, M. Stahle, F.O. Nestle, G. Girolomoni and J.G. Krueger, Psoriasis and systemic inflammatory diseases: Potential mechanistic links between skin disease and co-morbid conditions, J Invest Dermatol 130 (2010), 1785-1796.
12. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA 285 (2001), 2486-2497.
13. M. Fornal, R.A.Korbut, J. Królczyk andT. Grodzicki, Evolution of rheological properties of erythrocytes and left ventricular geometry in cardiovascular disease risk patients, Clin Hemorheol Microcirc 45 (2010), 155-159.
14. J.M. Gelfand, E.D. Dommasch and D.B. Shin, et al., The risk of stroke in patients with psoriasis, J Invest DermatoL 129 (2009), 2411-2418.
15. P. Gisondi, G. Tessari, A. Conti, S. Piaserico, S. Schianchi, A. Peserico, A. Giannetti and G. Girolomoni, Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case-control study, Br J Dermatol 157 (2007), 68-73. (Pubitemid 46934281)
16. A. Górnicki, Changes in erythrocyte microrheology in patients with psoriasis, Clin Exp Dermatol 29 (2004), 67-70. (Pubitemid 38183656)
17. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel and B.A. Franklin, et al., Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation 112 (2009), 285-290.
18. C. Irace, F. Scavelli, C. Carallo, R. Serra and A. Gnasso, Plasma and blood viscosity in metabolic syndrome, Nutr Metabol Cardiovasc Dis 19 (2009), 476-480.
19. F. Jung, H.G. Roggenkamp, R. Scheider and H. Kiesewetter, Das Kapillarschlauch-Plasmaviskosimeter ein neues Messgerät zur Quantifizierung der Blutplasmaviskosität, Biomed Technik 28 (1983), 249-252.
20. G.W. Kim, H.J. Park, H.S. Kim, H.C. Ko, B.S. Kim, M.B. Kim and E.K. Sim, Analysis of cardiovascular risk factors and metabolic syndrome in Korean patients with psoriasis, Ann Dermatol 24 (2012), 11-15.
21. T. Korotaeva, N. Firsov, E. Mach, E. Agababova and A. Burdeǐnyǐ, Microcirculatory disorders in patients with psoriatic arthritis, Ter Arkh 63 (1991), 78-82.
22. S. Langan, N.M. Seminara, D. Shin, A. Troxel, S. Kimmel, N. Mehta, D. Margolis and J. Gelfand, Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom, J Invest Dermatol 132 (2012), 556-562.
23. T.J. Love, A. Qureshi, E.Wood, J. Gelfand and H. Choi, Prevalence of the Metabolic Syndrome in Psoriasis. Results From the National Health and Nutrition Examination Survey, 2003-2006, Arch Dermatol 147 (2011), 419-424.
24. P. Mills, D. Quemada and J. Dufaux, Etude de la cinetique d'agregation erythrocytaire dans un écoulement Couette, Rev Phys Appl 15 (1980), 1357-1366.
25. S. Prey, C. Paul, V. Bronsard, E. Puzenat, P.A. Gourraud, S. Aractingi, F. Aubin, M. Bagot, B. Cribier, P. Joly, D. Jullien, M. Le Maittre, M.A. Richard-Lallemand and J.P. Ortonne, Cardiovascular risk factors in patients with plaque psoriasis: A systemic review of epidemiological studies, JEADV 24 (2010), 23-30.
26. S.K. Raychaudhuri, S. Chatterjee, C. Nguyen, M. Kaur, I. Jialal and S.P. Raychaudhuri, Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis, Metab Syndr Relat Disord 8 (2010), 331-334.
27. K. Reich, The concept of psoriasis as a systemic inflammation: Implications for disease management, JEADV 26 (2012), 3-11.
28. D. Sommer, S. Jenisch, M. Suchan, E. Christophers and M.Weichenthal, Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis, Arch Dermatol Res 298 (2006), 321-328.
29. W. Taylor, D. Gladman, P. Helliwell, A. Marchesoni, P. Mease and H. Mielants, CASPAR Study Group. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study, Arthritis Rheum 54 (2006), 2665-2673. (Pubitemid 44205029)
30. A. Vayá, A. Hernández-Mijares, E. Bonet, R. Sendra, E. Solá, R. Pérez, D. Corella and B. Laiz, Association between hemorheological alterations and metabolic syndrome, Clin Hemorheol Microcirc 49 (2011), 493-503.
31. G.A. Vena, M. Vestita and N. Cassano, Can early treatment with biologicals modify the natural history of comorbidities? Dermatol Ther 23 (2010), 181-193.